CRC shows a reduced number of infiltrating NK (NKp46+) cells compared to normal mucosa, also when CD8+ T cell numbers are elevated, suggesting that CRC is able to limit NK cell infiltration. This evidence concerns the gene NCR1 and colorectal carcinoma.